Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List

BACKGROUND: Evidence-based decision on drug list or formulary has been applied worldwide. Although the importance of scientific evidence was emphasized, the decision-making procedures for including medicines into the national reimbursement drug list were often challenged by their process opacity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenbin, Shi, Lizheng, Sawhney, Monika, Gu, Xiaoli, Chen, Yingyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369556/
https://www.ncbi.nlm.nih.gov/pubmed/30744609
http://dx.doi.org/10.1186/s12913-019-3937-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369556/
https://www.ncbi.nlm.nih.gov/pubmed/30744609
http://dx.doi.org/10.1186/s12913-019-3937-0

Ejemplares similares